Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Crumpacker

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Virology|September 15, 1996
AZT-related mutation Lys70Arg in reverse transcriptase of human immunodeficiency virus type 1 confers decrease in susceptibility to ddATP in in vitro RT inhibition assayP L Sharma, P A Chatis, A L Dogon, et al.
The New England Journal of Medicine|May 24, 1979
Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialisS L Spruance, C S Crumpacker, H Haines, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GROB J Dezube, A B Pardee, L A Beckett, et al.
Journal of Virology|December 1, 1988
Expression of herpes simplex virus type 1 DNA polymerase in Saccharomyces cerevisiae and detection of virus-specific enzyme activity in cell-free lysatesM L Haffey, J T Stevens, B J Terry, et al.
The Journal of Infectious Diseases|July 29, 2000
A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: a phase I studyB J Dezube, T A Dahl, T K Wong, et al.
The New England Journal of Medicine|August 27, 1992
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials GroupJ O Kahn, S W Lagakos, D D Richman, et al.
Annals of Internal Medicine|July 1, 1984
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacyJ L Dienstag, B G Werner, B F Polk, et al.
Blood|June 25, 1998
Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individualsJ E Schmitz, M A Forman, M A Lifton, et al.
Annals of Internal Medicine|August 1, 1985
Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccinationB G Werner, J L Dienstag, B J Kuter, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study GroupD L Mayers, A J Japour, J M Arduino, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Virology|September 15, 1996
AZT-related mutation Lys70Arg in reverse transcriptase of human immunodeficiency virus type 1 confers decrease in susceptibility to ddATP in in vitro RT inhibition assayP L Sharma, P A Chatis, A L Dogon, et al.
The New England Journal of Medicine|May 24, 1979
Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialisS L Spruance, C S Crumpacker, H Haines, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GROB J Dezube, A B Pardee, L A Beckett, et al.
Journal of Virology|December 1, 1988
Expression of herpes simplex virus type 1 DNA polymerase in Saccharomyces cerevisiae and detection of virus-specific enzyme activity in cell-free lysatesM L Haffey, J T Stevens, B J Terry, et al.
The Journal of Infectious Diseases|July 29, 2000
A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: a phase I studyB J Dezube, T A Dahl, T K Wong, et al.
The New England Journal of Medicine|August 27, 1992
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials GroupJ O Kahn, S W Lagakos, D D Richman, et al.
Annals of Internal Medicine|July 1, 1984
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacyJ L Dienstag, B G Werner, B F Polk, et al.
Blood|June 25, 1998
Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individualsJ E Schmitz, M A Forman, M A Lifton, et al.
Annals of Internal Medicine|August 1, 1985
Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccinationB G Werner, J L Dienstag, B J Kuter, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study GroupD L Mayers, A J Japour, J M Arduino, et al.
Pageof 9